SCTIMST Job Notification: Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has invited applications for the Scientific Administrative Assistant posts. Eligible and interested persons can apply for Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) Recruitment 2020 through the prescribed application format on or before 21 September 2020.
SCTIMST Recruitment 2020 to fill in 04 vacant posts. The Education organization invites applications for Scientific Administrative Assitant Posts from eligible persons having required qualifications. These posts are in Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Thiruvananthapuram, Kerala.
Important Date:
- Last Date for Submission of Application forms: 21 September 2020
SCTIMST Scientific Administrative Assistant Vacancy Details
- Scientific Administrative Assistant: 04 Posts
Eligibility Criteria for Scientific Administrative Assistant Job
Educational Qualification and Age Limit:
Graduate degree with first class in science, preferably life sciences, from a recognized university/institution. Age Limit: 35 years as on 31 August 2020.
Salary: Rs. 18000 per month + 16% HRA.
Official Notification Download Here | |
Official Website Link |
Download our Sarkari Naukri app from Play Store
How to Apply
Eligible and interested persons can apply for Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) Recruitment 2020 through the prescribed application format on or before 21 September 2020. Eligible persons may send their application in the prescribed format along with resume and self attested copies of certificates to prove age, qualifications, experience and non-creamy layer certificate (for OBC candidates) to Administrative Officer, Sree Chitra Tirunal Institute for Medical Sciences and Technology, BMT Wing, Poojappura, Thiruvananthapuram-695012 on or before 21 September 2020. The envelope should be superscribed as “Application for the post ofScientific Administrative Assistant”.
Comments
All Comments (0)
Join the conversation